Johan G C van Hasselt (J G Coen van Hasselt, J G C van Hasselt, Johan G C Van Hasselt)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Venues

Metabolomics : Official journal of the Metabolomic Society

CPT: pharmacometrics & systems pharmacology

Pharmaceutics

Nature communications

Universiteit Leiden

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universiteit Leiden Aug 01 2015

Netherlands

Assistant professor :: Pharmacology

Icahn School of Medicine at Mount Sinai Dec 01 2015 - Dec 01 2017

United States

Postdoctoral research fellow :: Pharmacological Sciences

Publications

Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Emma van Groesen, Elma Mons, Ioli Kotsogianni, Melina Arts, Kamaleddin H M E Tehrani, Nicola Wade, Vladyslav Lysenko, Florence M Stel, Jordy T Zwerus, Stefania De Benedetti, Alexander Bakker, Parichita Chakraborty, Mario van der Stelt, Dirk-Jan Scheffers, Jairo Gooskens, Wiep Klaas Smits, Kirsty Holden, Peter S Gilmour, Joost J Willemse, Christopher A Hitchcock, Johan G C van Hasselt, Tanja Schneider, Nathaniel I Martin
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity. Science translational medicine 16 (759) (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Emma van Groesen, Elma Mons, Ioli Kotsogianni, Melina Arts, Kamaleddin H M E Tehrani, Nicola Wade, Vladyslav Lysenko, Florence M Stel, Jordy T Zwerus, Stefania De Benedetti, Alexander Bakker, Parichita Chakraborty, Mario van der Stelt, Dirk-Jan Scheffers, Jairo Gooskens, Wiep Klaas Smits, Kirsty Holden, Peter S Gilmour, Joost J Willemse, Christopher A Hitchcock, Johan G C van Hasselt, Tanja Schneider, Nathaniel I Martin
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity. Science translational medicine 16 (759) (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Wisse Van Os, Markus Zeitlinger, Anh Duc Pham, Gert-Jan Wijnant, Perrin Ngougni Pokem, Françoise Van Bambeke, Johan G C van Hasselt, Markus Zeitlinger
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections. The Journal of antimicrobial chemotherapy (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Anyue Yin, G D Marijn Veerman, Johan G C van Hasselt, Christi M J Steendam, Hendrikus Jan Dubbink, Henk-Jan Guchelaar, Lena E Friberg, Anne-Marie C Dingemans, Ron H J Mathijssen, Dirk Jan A R Moes
Quantitative modeling of tumor dynamics and development of drug resistance in non-small cell lung cancer patients treated with erlotinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Ilona den Hartog, Laura B Zwep, Jacqueline J Meulman, Thomas Hankemeier, Ewoudt M W van de Garde, Johan G C van Hasselt
Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia. Metabolomics : Official journal of the Metabolomic Society 20 (2) (2024)
Divakar Budda, Berfin Gülave, Johan G C van Hasselt, Elizabeth C M De Lange
Non-linear blood-brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix. British journal of pharmacology (2024)
Yu Fu, Martijn van Noort, Tingjie Guo, Piet H van der Graaf, Johan G C van Hasselt
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies. Pharmaceutics 15 (4) (2023)
Laura B Zwep, Tingjie Guo, Thomas Nagler, Catherijne A J Knibbe, Jacqueline J Meulman, Johan G C van Hasselt
Virtual patient simulation using copula modeling. Clinical pharmacology and therapeutics (2023)
Magnus Bock, Johan G C van Hasselt, Franziska Schwartz, Hengzhuang Wang, Niels Høiby, Kurt Fuursted, Nikolaj Ihlemann, Sabine Gill, Ulrik Christiansen, Niels Eske Bruun, Hanne Elming, Jonas A Povlsen, Lars Valeur Køber, Dan E Høfsten, Emil L Fosbøl, Mia M Pries-Heje, Jens Jørgen Christensen, Flemming Schønning Rosenvinge, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tønder, Kasper Karmark Iversen, Henning Bundgaard, Claus Moser
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis. The Journal of antimicrobial chemotherapy (2023)
Yu Fu, Martijn van Noort, Tingjie Guo, Piet H van der Graaf, Johan G C van Hasselt
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies. Pharmaceutics 15 (4) (2023)
Yu Fu, Martijn van Noort, Tingjie Guo, Piet H van der Graaf, Johan G C van Hasselt
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies. Pharmaceutics 15 (4) (2023)
Yu Fu, Martijn van Noort, Tingjie Guo, Piet H van der Graaf, Johan G C van Hasselt
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies. Pharmaceutics 15 (4) (2023)
Linda B S Aulin, Sebastian T Tandar, Torben van Zijp, Etienne van Ballegooie, Piet H van der Graaf, Mohammed A A Saleh, Pyry Välitalo, Johan G C van Hasselt
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations. Clinical pharmacokinetics (2022)
Feiyan Liu, Linda B S Aulin, Tingjie Guo, Elke H J Krekels, Matthijs Moerland, Piet H van der Graaf, Johan G C van Hasselt
Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations. British journal of clinical pharmacology 88 (12) (2022)
Apostolos Liakopoulos, Linda B S Aulin, Matteo Buffoni, Efthymia Fragkiskou, Johan G C van Hasselt, Daniel E Rozen
Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Linda B S Aulin, Apostolos Liakopoulos, Piet H van der Graaf, Daniel E Rozen, Johan G C van Hasselt
Design principles of collateral sensitivity-based dosing strategies. Nature communications 12 (1) (2021)
Rayees Rahman, Nicole Zatorski, Jens Hansen, Yuguang Xiong, Johan G C van Hasselt, Eric A Sobie, Marc R Birtwistle, Evren U Azeloglu, Ravi Iyengar, Avner Schlessinger
Protein structure-based gene expression signatures. Proceedings of the National Academy of Sciences of the United States of America 118 (19) (2021)
Laura B Zwep, Yob Haakman, Kevin L W Duisters, Jacqueline J Meulman, Apostolos Liakopoulos, Johan G C van Hasselt
Identification of antibiotic collateral sensitivity and resistance interactions in population surveillance data. JAC-antimicrobial resistance 3 (4) (2021)
Johan G C van Hasselt, Rayees Rahman, Jens Hansen, Alan Stern, Jaehee V Shim, Yuguang Xiong, Amanda Pickard, Gomathi Jayaraman, Bin Hu, Milind Mahajan, James M Gallo, Joseph Goldfarb, Eric A Sobie, Marc R Birtwistle, Avner Schlessinger, Evren U Azeloglu, Ravi Iyengar
Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity. Nature communications 11 (1) (2020)
Maddalena Centanni, Dirk Jan A R Moes, Iñaki F Trocóniz, Joseph Ciccolini, Johan G C van Hasselt
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors. Clinical pharmacokinetics 58 (7) (2020)
Sílvia M Illamola, Catherine M T Sherwin, Johan G C van Hasselt
Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses. Clinical pharmacokinetics 57 (10) (2019)
Rhodora C Calizo, Smiti Bhattacharya, Johan G C van Hasselt, Chengguo Wei, Jenny S Wong, Robert J Wiener, Xuhua Ge, Nicholas J Wong, Jia-Jye Lee, Christina M Cuttitta, Gomathi Jayaraman, Vivienne H Au, William Janssen, Tong Liu, Hong Li, Fadi Salem, Edgar A Jaimes, Barbara Murphy, Kirk N Campbell, Evren U Azeloglu
Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nature communications 10 (1) (2019)
Yuguang Xiong, Magali Soumillon, Jie Wu, Jens Hansen, Bin Hu, Johan G C van Hasselt, Gomathi Jayaraman, Ryan Lim, Mehdi Bouhaddou, Loren Ornelas, Jim Bochicchio, Lindsay Lenaeus, Jennifer Stocksdale, Jaehee Shim, Emilda Gomez, Dhruv Sareen, Clive Svendsen, Leslie M Thompson, Milind Mahajan, Ravi Iyengar, Eric A Sobie, Evren U Azeloglu, Marc R Birtwistle
A Comparison of mRNA Sequencing with Random Primed and 3'-Directed Libraries. Scientific reports 7 (1) (2017)

Johan G C van Hasselt.css-eqlu8i{font-size:small;padding-left:4px;} (J G Coen van Hasselt, J G C van Hasselt, Johan G C Van Hasselt)

Publication Activity (10 Years)

Top Topics

Top Venues

Johan G C van Hasselt (J G Coen van Hasselt, J G C van Hasselt, Johan G C Van Hasselt)